Quantitative Investment Management, LLC
Position in ASND — Ascendis Pharma A/S
CIK 1445911
CHARLOTTESVILLE, VA
Position in ASND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$529,439
New position
Shares Held
1,985
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#219
of 307 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quantitative Investment Management, LLC holds $20,430,992 across 8 Biotechnology names. ASND ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,499 | $8,417,166 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,342 | $4,143,721 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,981 | $2,402,520 | |
| 4 | INSM |
INSMED Inc
|
15,894 | $1,694,618 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
41,416 | $1,615,638 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
16,631 | $1,301,708 | |
| 7 | ASND |
Ascendis Pharma A/S
This page
|
1,985 | $529,439 | |
| 8 | RXRX |
Recursion Pharmaceuticals, Inc.
|
88,878 | $326,182 |
All Filings in ASND
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $529,439 | 1,985 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||